2023 annual financial data
Tango Therapeutics 2023 Operating margin
Direct answer
Operating margin was -312.57%.
Operating income was -114,173,000 USD and net income was -101,744,000 USD.
Operating cash flow was -117,982,000 USD.
Get free Tango Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 36,527,000 USD
- Operating income
- -114,173,000 USD
- Net income
- -101,744,000 USD
- Operating cash flow
- -117,982,000 USD